MedWatch

Abacus pumps money into ailing Dutch client

Danish parallel importer Abacus Medicine has invested in a Dutch client that suffered a great financial loss after a disastrous implementation of a new IT system and is short of money.

Foto: Abacus Medicine

Flemming Wagner, CEO in the parallel importer Abacus Medicine, has used untraditional means to save one of the company's best customers.

Abacus has invested an undisclosed sum in Dutch Pluripharm, one of The Netherlands' largest pharmaceutical wholesalers. In 2017, Pluripharm has a revenue of EUR 480 million (USD 544.4 million), the company is a "strategically important" client for Abacus.

Læs hele artiklen

Få 14 dages fri adgang.
Det kræver intet kreditkort.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier